Unknown

Dataset Information

0

G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis.


ABSTRACT: Atherosclerosis, the underlying cause of the majority of cardiovascular diseases (CVDs), is a lipid-driven, inflammatory disease of the large arteries. Gold standard therapy with statins and the more recently developed proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have improved health conditions among CVD patients by lowering low density lipoprotein (LDL) cholesterol. Nevertheless, a substantial part of these patients is still suffering and it seems that 'just' lipid lowering is insufficient. The results of the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) have now proven that inflammation is a key driver of atherosclerosis and that targeting inflammation improves CVD outcomes. Therefore, the identification of novel drug targets and development of novel therapeutics that block atherosclerosis-specific inflammatory pathways have to be promoted. The inflammatory processes in atherosclerosis are facilitated by a network of immune cells and their subsequent responses. Cell networking is orchestrated by various (inflammatory) mediators which interact, bind and induce signaling. Over the last years, G-protein coupled receptors (GPCRs) emerged as important players in recognizing these mediators, because of their diverse functions in steady state but also and specifically during chronic inflammatory processes - such as atherosclerosis. In this review, we will therefore highlight a selection of these receptors or receptor sub-families mainly expressed on myeloid cells and their role in atherosclerosis. More specifically, we will focus on chemokine receptors, both classical and atypical, formyl-peptide receptors, the chemerin receptor 23 and the calcium-sensing receptor. When information is available, we will also describe the consequences of their targeting which may hold promising options for future treatment of CVD.

SUBMITTER: van der Vorst EPC 

PROVIDER: S-EPMC6540917 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis.

van der Vorst Emiel P C EPC   Peters Linsey J F LJF   Müller Madeleine M   Gencer Selin S   Yan Yi Y   Weber Christian C   Döring Yvonne Y  

Frontiers in pharmacology 20190522


Atherosclerosis, the underlying cause of the majority of cardiovascular diseases (CVDs), is a lipid-driven, inflammatory disease of the large arteries. <i>Gold standard</i> therapy with statins and the more recently developed <i>proprotein convertase subtilisin/kexin type 9</i> (PCSK9) inhibitors have improved health conditions among CVD patients by lowering <i>low density lipoprotein</i> (LDL) cholesterol. Nevertheless, a substantial part of these patients is still suffering and it seems that '  ...[more]

Similar Datasets

| S-EPMC4274506 | biostudies-literature
| S-EPMC7945687 | biostudies-literature
| S-EPMC9645299 | biostudies-literature
| S-EPMC6409483 | biostudies-literature
| S-EPMC3321515 | biostudies-literature
| S-EPMC3013369 | biostudies-literature
| S-EPMC4169583 | biostudies-literature
| S-EPMC8345100 | biostudies-literature
| S-EPMC5347560 | biostudies-literature
| S-EPMC7551713 | biostudies-literature